ANGPT2 and breast cancer: In a recent study on the epigenetic state of the miR-145 promoter, methylation of the miR-145 promoter has been reported as a probable mechanism for its reduced expression, while demethylation leads to inhibition of migration and invasion of breast cancer cells through targeting the angiopoietin 2 gene [34].